These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

204 related items for PubMed ID: 16515449

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Protein aggregation and aggregate toxicity: new insights into protein folding, misfolding diseases and biological evolution.
    Stefani M, Dobson CM.
    J Mol Med (Berl); 2003 Nov; 81(11):678-99. PubMed ID: 12942175
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. The amyloid state and its association with protein misfolding diseases.
    Knowles TP, Vendruscolo M, Dobson CM.
    Nat Rev Mol Cell Biol; 2014 Jun; 15(6):384-96. PubMed ID: 24854788
    [Abstract] [Full Text] [Related]

  • 7. What the use of disease-unrelated model proteins can tell us about the molecular basis of amyloid aggregation and toxicity.
    Stefani M.
    Ital J Biochem; 2003 Dec; 52(4):162-76. PubMed ID: 15141483
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Protein misfolding, aggregation and mechanism of amyloid cytotoxicity: An overview and therapeutic strategies to inhibit aggregation.
    Zaman M, Khan AN, Wahiduzzaman, Zakariya SM, Khan RH.
    Int J Biol Macromol; 2019 Aug 01; 134():1022-1037. PubMed ID: 31128177
    [Abstract] [Full Text] [Related]

  • 12. On the structural definition of amyloid fibrils and other polypeptide aggregates.
    Fändrich M.
    Cell Mol Life Sci; 2007 Aug 01; 64(16):2066-78. PubMed ID: 17530168
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Evaluation of Aggregation and Fibril Formation Propensity of Peptides Involved in Amyloid Diseases.
    Malavolta L, Chinarelli RL, Sobral DV, Nakaie CR.
    Protein Pept Lett; 2018 Feb 08; 24(12):1141-1147. PubMed ID: 29086671
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Conformation-dependent scFv antibodies specifically recognize the oligomers assembled from various amyloids and show colocalization of amyloid fibrils with oligomers in patients with amyloidoses.
    Zhang X, Sun XX, Xue D, Liu DG, Hu XY, Zhao M, Yang SG, Yang Y, Xia YJ, Wang Y, Liu RT.
    Biochim Biophys Acta; 2011 Dec 08; 1814(12):1703-12. PubMed ID: 21979582
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.